Aventis Finally Succumbs to Sanofi-Synthelabo's Advances
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 48 (Table of Contents)
Published: 4 Jun-2004
DOI: 10.3833/pdr.v2004.i48.805 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Aventis which initially rejected the hostile bid succumbs to the improved takeover offer (bid value from €48 to €55 B and including a greater cash component) from Sanofi-Synthelabo...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS